Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Issued
Ratios

Arcus Biosciences (RCUS) Leases (2020 - 2022)

Historic Leases for Arcus Biosciences (RCUS) over the last 3 years, with Q3 2022 value amounting to $102.1 million.

  • Arcus Biosciences' Leases rose 18672.19% to $102.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $102.1 million, marking a year-over-year increase of 18672.19%. This contributed to the annual value of $105.0 million for FY2021, which is 72128.16% up from last year.
  • As of Q3 2022, Arcus Biosciences' Leases stood at $102.1 million, which was up 18672.19% from $104.0 million recorded in Q2 2022.
  • Arcus Biosciences' 5-year Leases high stood at $105.0 million for Q4 2021, and its period low was $12.2 million during Q1 2021.
  • Its 3-year average for Leases is $63.9 million, with a median of $69.1 million in 2021.
  • Examining YoY changes over the last 5 years, Arcus Biosciences' Leases showed a top increase of 74123.17% in 2022 and a maximum decrease of 18672.19% in 2022.
  • Quarter analysis of 3 years shows Arcus Biosciences' Leases stood at $12.8 million in 2020, then skyrocketed by 721.28% to $105.0 million in 2021, then fell by 2.76% to $102.1 million in 2022.
  • Its Leases was $102.1 million in Q3 2022, compared to $104.0 million in Q2 2022 and $103.0 million in Q1 2022.